Next Article in Journal
Nodding Syndrome: A Scoping Review
Previous Article in Journal
Knowledge, Attitudes and Practices Regarding Sylvatic Rabies among High-Risk Households in Ceará State, Brazil
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Occurrence of Cryptosporidium Infection and Associated Risk Factors among HIV-Infected Patients Attending ART Clinics in the Central Region of Ghana

by
Kwabena Dankwa
1,2,*,
Samuel Victor Nuvor
2,
Dorcas Obiri-Yeboah
2,3,
Patrick Kwame Feglo
1 and
Mohamed Mutocheluh
1
1
Department of Clinical Microbiology, Kwame Nkrumah University of Science and Technology, Private Mail Bag, University Post Office, Kumasi, Ghana
2
Department of Microbiology and Immunology, University of Cape Coast, Private Mail Bag, University Post Office, Cape Coast, Ghana
3
Directorate of Research, Innovation, and Consultancy, University of Cape Coast, Private Mail Bag, University Post Office, Cape Coast, Ghana
*
Author to whom correspondence should be addressed.
Trop. Med. Infect. Dis. 2021, 6(4), 210; https://doi.org/10.3390/tropicalmed6040210
Submission received: 29 October 2021 / Revised: 17 November 2021 / Accepted: 21 November 2021 / Published: 9 December 2021

Abstract

:
Cryptosporidium species are intestinal protozoan parasites that infect and cause diarrhoea in animals and humans. The current study was conducted to determine the prevalence and risk factors of Cryptosporidium infection among HIV-infected patients in the Central region of Ghana. In this cross-sectional study, four hundred eighteen documented HIV-infected participants from four health facilities that provide antiretroviral therapy (ART) services across the Central region of Ghana were selected by systematic random sampling. An enzyme-linked immunosorbent assay (CoproELISATM, Cryptosporidium Savyon® Diagnostics Ltd., Ashdod, Israel) was used to detect Cryptosporidium antigens in stool samples obtained from participants. Information regarding participants’ sociodemographic characteristics and clinical symptoms as well as potential environmental and behavioral risk factors were collected using a structured questionnaire. Chi-square or Fisher’s exact tests were used to determine associations between Cryptosporidium infections and explanatory variables, while risk factors were assessed using multivariate logistic regression analysis. The overall prevalence of Cryptosporidium infection among HIV-infected participants in this study was 6.2% (95% CI: 3.90–8.54). Cryptosporidium was not significantly associated with any of the sociodemographic variables, patient clinical symptoms, and environmental factors. However, the prevalence of the parasite was significantly higher 25% (95% CI: 1.17–48.83; p = 0.013) among participants who did not always wash their hands before meals and those who did not always wash vegetables before eating them, 23.5% (95% CI: 1.05–46.01; p = 0.016). Multivariate logistic regression analysis showed that participants who used public water closet facilities were approximately 9 times more likely to become infected with the parasite than those who practised open defecation (OR: 8.83; 95% CI: 1.22–64.13; p = 0.031). In conclusion, Cryptosporidium is prevalent among HIV-infected patients in the Central region of Ghana. An important risk factor identified was the use of the public water closet toilet facility. More attention should be given to ensuring cleanliness at shared water closet facilities in addition to adequate disinfection of hands after using such facilities.

1. Introduction

Cryptosporidium species are apicomplexan parasites that infect man and other vertebrates [1,2]. Currently, more than 38 species of the parasite have been described worldwide with Cryptosporidium hominis and Cryptosporidium parvum implicated in most human infections [3,4]. Cryptosporidium infection in immunocompetent hosts is usually self-limiting but can be severe and prolonged in immunocompromised individuals [5].
Infections caused by Cryptosporidium species partly contribute to the high number of diarrhoea cases among immune-compromised persons and children [6,7,8]. The Global Enteric Multicenter Study (GEMS) revealed the parasite as a significant contributor to the diarrhoea burden in children less than two years old in sub-Saharan Africa [9]. This is because of the ubiquitous and robust nature of the oocysts of the parasite, which is transmitted either directly from person to person or indirectly through vehicles such as contaminated food or water, or from animals to humans [10,11].
Cryptosporidium has been reported in several studies among HIV-positive individuals around the world with a prevalence ranging from 2.17% to 55% in China, Uganda, Kenya, Congo Democratic Republic, Ethiopia, and Nigeria [12,13,14,15,16,17,18]. In Ghana, hospital-based studies among HIV-infected participants in the Ashanti and Central regions have reported prevalences of 14% and 46%, respectively [19,20].
Methods available for the detection of Cryptosporidium infections in stool samples include conventional microscopy to identify oocysts on stained slides and immunological assays based on the detection of Cryptosporidium antigens by immunochromatography or enzyme-linked immunosorbent assay (ELISA). Currently, molecular methods such as real-time polymerase chain reaction (RT-PCR), polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP), and PCR—sequencing protocols are used in the identification of genotypes/species of the parasite [21,22,23]. It must however be noted that most of the studies on Cryptosporidium in Ghana utilized conventional microscopy [6,18,20]. Although ELISA has proven in many cases to be more sensitive in the detection of Cryptosporidium species than microscopy, its use is limited to a few studies in Ghana [24,25,26].
Globally, HIV infections currently stand at about 37.6 million people with adults (15 years and above) constituting 95% of the infected population [27]. In Ghana, the adult HIV prevalence is estimated at 1.7%, with less than half of them receiving anti-retroviral drugs, a situation which makes the HIV-infected population vulnerable to many infections, including Cryptosporidium [27,28,29]. Some of the risk factors that contribute to Cryptosporidium infection, in general, are related to contaminated food and drinking water sources, contact with infected animals, crowded living conditions and contact with children in diapers [20,30,31]. However, potential risk factors for Cryptosporidium infection among HIV-infected persons in the Central region are poorly understood. The only study that explored the problem was limited with sample size but implicated the source of drinking water as a risk factor [20]. The goal of this study was to determine the prevalence and risk factors of Cryptosporidium infection among HIV-infected patients in the Central region of Ghana.

2. Materials and Methods

2.1. Study Design/Sites

This was a health facility-based cross-sectional study carried out in the Central region, one of Ghana’s 16 political administrative areas occupying a total land area of 9826 square kilometers with a population of approximately 2,201,863 people [32]. The region lies across the coastal and forest ecological zones in the southern part of Ghana with a local economy based on fishing, farming, tourism, and trading, among others. The four health facilities included in this study were the HIV clinics of The Cape Coast Teaching Hospital, St Francis Xavier Hospital at Assin Foso, Ewim Polyclinic in Cape Coast, and the Elmina Polyclinic at Elmina (Figure 1). These facilities offer medical care and antiretroviral therapy (ART) services to many registered HIV patients in the region and were purposely selected because of the large number of patients they serve. The clinic at the Cape Coast Teaching hospital is a referral facility, which provides specialized services to registered HIV patients across the region and beyond.

2.2. Study Population/Sampling/Sample Size

The study involved documented HIV-infected patients with or without diarrhoea attending HIV clinics in the selected health facilities. Participants were recruited by systematic random sampling. A sample interval was determined based on the total number of patients at the clinic. A participant was then chosen among the first three at random. Every other third participant was then selected for the study. The eligibility criteria for participants included being 18 years of age or older, being resident in the Central region, having the ability to provide a stool sample and answer a questionnaire. As reliable data on Cryptosporidium infections among HIV/AIDS patients 18 years or older were not readily available, the prevalence was estimated at 50% with a margin of error of 5%, at 95% level of confidence, and an expected response rate of 0.9 by Cochran’s formula [33]. A minimum number of 384 participants was required, but in all 418 participants took part in the study. The number of participants allocated per study facility was based on the number of patients seen in the clinic within 3 months before the study.

2.3. Sample Collection

A single fresh stool sample was obtained from each participant at the various health facilities included in the study between December 2018 and July 2019. The participants were given labelled screw-capped plastic containers with a spoon for the collection of the samples. They were also given instructions on how to collect the samples without it getting contaminated with urine. The samples were kept on ice and sent to the laboratory of the School of Medical Sciences, University of Cape Coast where a portion of each was preserved in 10% formalin for further analysis as was required by the commercial ELISA kit used in the study. A portion of the stool sample was also stored at −20 °C for future molecular work.

2.4. Questionnaire Administration

A structured questionnaire was administered to the study participants to identify risk factors associated with Cryptosporidium infection. The questionnaire captured socio-demographic information, the clinical symptoms within 2 weeks before sample collection as well as some environmental and behavioural risk factors of participants. Information on whether participants were on antiretroviral therapy and duration was also obtained.

2.5. Detection of Cryptosporidium Stool Antigens

The study utilized a commercial enzyme-linked immunosorbent assay stool kit (CoproELISATM Cryptosporidium, Savyon® Diagnostics Ltd., Ashdod, Israel) for the qualitative detection of Cryptosporidium antigens in participants stool samples. The procedure outlined by the manufacturer was duly followed using the 10% formalin preserved stool samples. Briefly, all components of reagents used in the test were brought to room temperature. For each test, one positive and two negative controls were always run along with the samples in a 96 well microtiter plate. A dilution tube was set up for each formalin preserved stool sample in a 1.5 mL Eppendorf tube where 0.15 g or 0.15 mL of stool sample was added to 400 μL of stool diluent using a disposable collector. The faecal specimen was then vortexed and left to stand for at least 10 min but not more than 30 min to allow large particles of materials to precipitate.
One hundred microliters each of the positive control, negative controls in duplicate, and the same volume of diluted samples were dispensed into the wells of the microtiter plate (coated with anti-cryptosporidium antibodies) using disposable pipettes. The plate was then incubated at 37 °C in a moisture chamber for 1 h. This was followed by a washing step with 300 μL of wash buffer 5 times after which 100 μL of the conjugate was then added to each well and incubated for 1 h at 37 °C in a moisture chamber. The ELISA plates were then washed with buffer 5 times.
Finally, 100 μL of TMB-substrate was added to each well and incubated at room temperature for 15 min after which the reaction was stopped by adding 100 μL of stop solution (1M H2SO4) into each well. The absorbance at 450 nm was measured with a Multiskan EX ELISA plate reader(Thermo Scientific, Waltham, MA, USA. The results were then printed out and used in interpreting the test. A cut-off value was determined using the mean absorbance value of the negative control plus 0.3. The results of the test were interpreted as negative (Cryptosporidium antigens not detectable) when the optical density of the sample was less than the cut-off value and positive (detectable Cryptosporidium antigens) when it was equal to or more than the cut-off value.

2.6. Ethical Considerations

The study protocol was reviewed and approved by the Committee on Human Research Publication and Ethics at the Kwame Nkrumah University of Science and Technology in Kumasi, Ghana (CHRPE/AP/550/18), and the Ethical Review Committee of the Cape Coast Teaching Hospital (CCTHERC/EC/2018/4) before commencement. Permission was also obtained from the other participating health facilities. The goals of the study were explained to all participants who were included only after they gave written informed consent. In addition, the administration of the questionnaire was done in designated offices of the health facilities to ensure privacy, guarantee confidentiality and avoid any distractions to participants.

2.7. Statistical Analysis

Data from the questionnaire and corresponding results of the laboratory tests of the participants were entered into IBM’s SPSS statistics for windows version 25.0 (IBM Corp.: Armonk, NY, USA) for statistical analysis. Continuous variables were summarized using descriptive statistics such as the mean and standard deviation while for categorical variables we used frequencies and proportions. The associations between Cryptosporidium infection and sociodemographic and other explanatory variables were assessed using Pearson’s Chi-square or Fisher’s exact test where appropriate. The risk factors were assessed using multivariate logistic regression analysis. Odds ratios were determined at 95% confidence intervals (CI) in the model to measure the strength of association between the dependent and independent variables. In these analyses, p ≤ 0.05 was considered statistically significant.

3. Results

3.1. Sociodemographic Characteristics of Participants

A total of 418 HIV-positive patients were involved in the study. The mean age of the participants was 45.8 (±11.7) years while the range was between 18 and 77 years. A greater proportion of participants in the study (41.1%) were in the 45–59-year age bracket. There were more females (81.6%) than males, while most participants were involved in trading (39.2%). Approximately a quarter of participants (25.4%) in the study had no formal education while the majority (60.8%) had household size with 5 members or less. Additionally, most participants (70.8%) were residents in urban areas while only a few (5.5%) had yet to receive antiretroviral treatment (Table 1).

3.2. Prevalence and Association between Cryptosporidium Infection and Participants Characteristics and Symptoms

The overall prevalence of Cryptosporidium infection in this study was 6.2% (95% CI: 3.90–8.54). Generally, there was no significant association between Cryptosporidium infection and any of the sociodemographic variables (Table 2). The prevalence of Cryptosporidium was higher in males (10.4%), among those who were not working (8.7%), those in the 30–44-year category (9.4%) and participants with no formal education (8.5%). However, the prevalence rate of the parasite was lower (5.5%) among participants with more than 5 members in their households and those residing in rural areas (5.7%).
With regards to the clinical symptoms of participants and infection with the parasite, there was no association. The prevalence of Cryptosporidium infection was however higher among participants with nausea (7.1%) and abdominal pains (7.5%). The prevalence was also higher (8.4%) among participants who had been on antiretroviral treatment between 1–12 months (Table 3).

3.3. Association between Environmental, Behavioral Risk Factors and Cryptosporidium Infection

There were no associations between any of the environmental factors and Cryptosporidium infection (Table 4). Participants who used tap water as main source for drinking, those who used public water closets and those who had pets at home had higher rates of infection. Cryptosporidium infection was associated with some behavioural factors of participants in the study such as not washing hands before meals (p = 0.013) and not washing vegetables before eating them (p = 0.016) (Table 5). There was however no association between washing fruits before eating, washing hands with soap after visiting the toilet and changing children’s diapers.

3.4. Risk Factors for Cryptosporidium Infection

In the multivariate logistic regression analysis (Table 6), the use of public water closet toilet facilities by participants was the only significant predictor for Cryptosporidium infection. Participants who used public water closets had higher odds of becoming infected with Cryptosporidium than those who practiced open defecation (OR 8.83; CI: 1.22–64.13, p = 0.031) Participants who did not always wash their hands before meals, those who did not always wash vegetables before eating and the others who indicated that did not always wash fruits before eating them also had increased risks of Cryptosporidium infection, but these were not statistically significant.

4. Discussion

Cryptosporidium species are a common cause of diarrhoea among HIV patients, other immunocompromised individuals as well as in immunocompetent persons. Information about the parasite and factors associated with its infection, especially among HIV-infected individuals in Ghana is however limited. This study was carried out to determine the occurrence and associated risk factors of Cryptosporidium species among HIV-infected patients in the Central region of Ghana using an antigen detecting enzyme-linked immunosorbent assay.
The overall prevalence of Cryptosporidium infection among the HIV-infected population in this study was 6.2%. Studies carried out earlier in different parts of the country, showed varied levels of prevalence of the parasite. The occurrence of the parasite in the current study is lower than that in studies conducted in other parts of Ghana such as Cape Coast, Kumasi, Accra, and Tarkwa, which reported prevalence of between 11% and 46% [6,19,20,34,35]. The prevalence of Cryptosporidium infection in the current study is however higher than that in a similar study on intestinal parasites and HIV/AIDS coinfections in Offinso and Nyinahin hospitals in the Ashanti region of Ghana which recorded a Cryptosporidium prevalence of 2.1% [18]. Other studies among HIV individuals in Mozambique, Kenya, Thailand, Iran, and Ethiopia have reported prevalence between 8.9% and 26.3% [14,16,36,37,38], which were higher than those obtained in the present study. However, the prevalence in the current study was higher compared to studies in Nigeria, North India, and the Democratic Republic of Congo [39,40,41]. Several explanations may account for the varying prevalence recorded in various studies of the parasite. These include factors such as whether the study population had diarrhoea or not or whether participants were on highly active antiretroviral therapy, the diagnostic method used, the season of sampling and location of study, among others. It is also likely that the prevalence of Cryptosporidium infection may not depend on all these factors but some of them.
The relatively low prevalence of the parasite in the present study could also be because of the high proportion of participants on highly active antiretroviral therapy (HAART). Similar studies from Ghana and other countries among HIV-positive patients on HAART treatment have reported significant improvement in their immunological status [42,43]. Thus, therapeutic measures aimed at improving the immune status of HIV-infected patients contribute significantly to reducing the prevalence of the parasite.
The detection method of the parasite could also have accounted for the level of prevalence recorded in the present study. A previous study in the Central region of Ghana using the modified Ziehl Neelsen (ZN) staining method reported a Cryptosporidium prevalence of 46% which was quite high, but one of the strengths of the current study is the large sample size [20]. It must be pointed out that even though the modified Ziehl Neelsen (ZN) method is most widely used for detecting Cryptosporidium in Ghana and other places in Africa [44], the sensitivity of the ELISA technique is reported to be superior with the capacity to detect Cryptosporidium antigens even in the absence of oocysts [25].
In addition, a higher prevalence of Cryptosporidium is usually associated with individuals presenting with diarrhoea. However, the prevalence of the parasite in the current study was lower than that in an earlier study in a tertiary hospital in Ghana which involved HIV-infected patients with chronic diarrhoea and reported a 46% prevalence rate [20]. This may be because only approximately a quarter of participants in the current study reported having diarrhoea.
The lack of association between Cryptosporidium infection and the various factors in our study may be because of improvement in the immune status of the patients. This is because most of the participants in the study were on antiretroviral therapy, which reduces the impact of the disease on affected individuals as it improves their CD4+ T-lymphocyte levels and reduces their viral load [45]. However, Cryptosporidium infection was found to be significantly higher among participants who did not wash their hands before meals as well as those who did not always wash vegetables before eating them. Contaminated hands resulting from inadequate hand hygiene facilitate the transmission of the parasite as was reported in a study among veterinary students following the handling of animals on the farm [46]. Hand washing before meals is therefore important in preventing contamination of food and ingestion of oocysts of the parasite.
The observation of an association between Cryptosporidium infection and participants not washing vegetables is similar to the findings of a study in Spain [47]. There are some studies in Ghana and other countries that also reported the contamination of vegetables with oocysts of the parasite [47,48,49]. The oocysts are hardy and readily infectious immediately they are passed out by the host into the environment and only adequate disinfection of the vegetables can prevent consumers from getting infected.
Participants who used public water closets were approximately 9 times more likely to be infected with Cryptosporidium than those who practiced open defecation. This finding is quite surprising as the use of water closet is apparently more hygienic than the practice of open defecation. Even though the water closet is considered as an ‘improved sanitation’ facility, a general lack of cleanliness that characterizes most of the shared public toilet facilities [50] may account for this observation. Shared toilets have been reported to be associated with diarrhoea and other diseases in Uganda [51] and are therefore classified as limited sanitation by the WHO/UNICEF-Joint Monitoring Program (JMP) for water supply and sanitation because of their unhygienic and poorly managed nature [52].
It must also be noted that this study was not without any limitations. Key among them was the detection of Cryptosporidium antigens using ELISA which did not offer any information on the species of the parasite involved. We were, therefore, unable to ascertain whether some of the infecting species were zoonotic. Employing molecular detection methods in future studies would help in the identification of species/genotypes and sub-types of the parasite. Again, no information was collected on the nature and state of hand hygiene facilities available at these public toilet facilities, and this should also be addressed in future studies.

5. Conclusions

Cryptosporidium species is prevalent among HIV-infected patients in the Central region of Ghana at 6.2%. The use of the public water closet facility was identified as an important risk factor. We recommend that more attention be given to shared public water closet toilet facilities in terms of cleanliness. HIV-infected patients should also ensure adequate disinfection of hands after visiting such facilities.

Author Contributions

Conceptualization, K.D., M.M. and P.K.F.; methodology, K.D., M.M., S.V.N. and D.O.-Y.; formal analysis, K.D. and S.V.N.; investigation, K.D.; resources, K.D.; data curation, K.D.; writing—original draft preparation, K.D.; writing—review and editing, K.D., M.M., P.K.F., S.V.N. and D.O.-Y.; visualization, K.D., S.V.N.; supervision, M.M., D.O.-Y., S.V.N. and P.K.F.; project administration, K.D.; funding acquisition, K.D. All authors have read and agreed to the published version of the manuscript.

Funding

This study was partly funded by The University of Cape Coast, PhD research support grant for K.D.

Institutional Review Board Statement

The study was conducted according to the guidelines of the Declaration of Helsinki and approved by the Committee on Human Research Publication and Ethics at the Kwame Nkrumah University of Science and Technology (CHRPE/AP/550/18), and the Ethical Review Committee of the Cape Coast Teaching Hospital (CCTHERC/EC/2018/4).

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Data Availability Statement

The data presented in this study are available on request from the corresponding author.

Acknowledgments

We are grateful to Prince Karikari, Vincent Agboyi Lakpo, Evans Obboh, Samuel Donkor and Ben Johnson for assisting with sample/data collection and laboratory work. We thank the administrators and nurses at the various health facilities for their support during patient recruitment and sample collection. Finally, we thank all participants who took part in the study.

Conflicts of Interest

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.

References

  1. Certad, G.; Follet, J.; Gantois, N.; Hammouma-Ghelboun, O.; Guyot, K.; Benamrouz-Vanneste, S.; Fréalle, E.; Seesao, Y.; Delaire, B.; Creusy, C.; et al. Prevalence, Molecular Identification, and Risk Factors for Cryptosporidium Infection in Edible Marine Fish: A Survey Across Sea Areas Surrounding France. Front. Microbiol. 2019, 10, 1037. [Google Scholar] [CrossRef] [Green Version]
  2. Ravich, M.L.; Reavill, D.R.; Hess, L.; Childress, A.L.; James, F.X.; Wellehan, J.F., Jr. Gastrointestinal Cryptosporidiosis in Captive Psittacine Birds in the United States: A Case Review Gastrointestinal Cryptosporidiosis in Captive Psittacine Birds in the United States: A Case Review. J. Avian Med. Surg. 2014, 28, 297–303. [Google Scholar] [CrossRef]
  3. Ryan, U.; Zahedi, A.; Paparini, A. Cryptosporidium in humans and animals—A one health approach to prophylaxis. Parasite Immunol. 2016, 38, 535–547. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  4. Innes, E.A.; Chalmers, R.M.; Wells, B.; Pawlowic, M.C. A One Health Approach to Tackle Cryptosporidiosis. Trends Parasitol. 2020, 36, 290–303. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  5. Current, W.L.; Garcia, L.S. Cryptosporidiosis. Clin. Microbiol. Rev. 1991, 4, 325–358. [Google Scholar] [CrossRef] [PubMed]
  6. Bosompem, K.M.; Adjei, A.A.; Lartey, M.; Adiku, T.K.; Rodrigues, O.; Renner, L.; Sifah, E.; Mensah, J.D.; Akanmori, B.; Otchere, J.; et al. Cryptosporidium oocysts in Ghanaian AIDS patients with diarrhoea. E. Afr. Med. J. 2004, 80, 369–372. [Google Scholar] [CrossRef]
  7. Amin, M.M.; Dyab, A.K.; Monib, M.E.-S.M.; Hawary, B.; Desoky, R.M. Cryptosporidiosis in Immunocompromised Children. Egypt. J. Med. Microbiol. 2018, 27, 143–149. [Google Scholar] [CrossRef]
  8. Wang, R.-J.; Li, J.-Q.; Chen, Y.-C.; Zhang, L.-X.; Xiao, L.-H. Widespread occurrence of Cryptosporidium infections in patients with HIV/AIDS: Epidemiology, clinical feature, diagnosis, and therapy. Acta Trop. 2018, 187, 257–263. [Google Scholar] [CrossRef]
  9. Sow, S.O.; Muhsen, K.; Nasrin, D.; Blackwelder, W.C.; Wu, Y.; Farag, T.H.; Panchalingam, S.; Sur, D.; Zaidi, A.K.M.; Faruque, A.S.G.; et al. The Burden of Cryptosporidium Diarrheal Disease among Children <24 Months of Age in Moderate/High Mortality Regions of Sub-Saharan Africa and South Asia, Utilizing Data from the Global Enteric Multicenter Study (GEMS). PLoS Negl. Trop. Dis. 2016, 10, e0004729. [Google Scholar] [CrossRef] [Green Version]
  10. Thompson, R.A.; Koh, W.H.; Clode, P.L. Cryptosporidium—What is it? Food Waterborne Parasitol. 2016, 4, 54–61. [Google Scholar] [CrossRef] [Green Version]
  11. Korpe, P.S.; Gilchrist, C.; Burkey, C.; Taniuchi, M.; Ahmed, E.; Madan, V.; Castillo, R.; Ahmed, S.; Arju, T.; Alam, M.; et al. Case-Control Study of Cryptosporidium Transmission in Bangladeshi Households. Clin. Infect. Dis. 2018, 68, 1073–1079. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  12. Tian, L.-G.; Chen, J.-X.; Wang, T.-P.; Cheng, G.-J.; Steinmann, P.; Wang, F.-F.; Cai, Y.-C.; Yin, X.-M.; Guo, J.; Zhou, L.; et al. Co-infection of HIV and intestinal parasites in rural area of China. Parasites Vectors 2012, 5, 36. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  13. Nakibirango, J.; Mugenyi, V.; Nsaba, D.; Nsimemukama, A.; Rugera, S.P.; Okongo, B. Prevalence of cryptosporidiosis and hygiene practices among HIV/AIDS patients in southwest Uganda. HIV/AIDS Res. Palliat. Care 2019, ume 11, 141–145. [Google Scholar] [CrossRef] [Green Version]
  14. Nyamwange, C.; Mkoji, G.M.; Mpoke, S. Cryptosporidiosis among HIV positive patients in the North Rift region of Kenya. Afr. J. Health Sci. 2012, 21, 92–106. [Google Scholar]
  15. Longo-Mbenza, B.; Wumba, R.; Menotti, J.; Mandina, M.; Kintoki, F.; Situakibanza, N.H.; Kakicha, M.K.; Zanga, J.; Mbanzulu-Makola, K.; Nseka, T.; et al. Epidemiology, clinical, immune, and molecular profiles of microsporidiosis and cryptosporidiosis among HIV/AIDS patients. Int. J. Gen. Med. 2012, 5, 603–611. [Google Scholar] [CrossRef] [Green Version]
  16. Adamu, H.; Petros, B.; Zhang, G.; Kassa, H.; Amer, S.; Ye, J.; Feng, Y.; Xiao, L. Distribution and Clinical Manifestations of Cryptosporidium Species and Subtypes in HIV/AIDS Patients in Ethiopia. PLoS Negl. Trop. Dis. 2014, 8, e2831. [Google Scholar] [CrossRef] [Green Version]
  17. Obateru, O.; Bojuwoye, B.; Olokoba, A.; Fadeyi, A.; Fowotade, A. Prevalence of intestinal parasites in newly diagnosed HIV/AIDS patients in Ilorin, Nigeria. Alex. J. Med. 2017, 53, 111–116. [Google Scholar] [CrossRef] [Green Version]
  18. Tay, S.C.; Aryee, E.N.O.; Badu, K. Intestinal Parasitemia and HIV/AIDS Co-infections at Varying CD4+ T-cell Levels. HIV/AIDS Res. Treat. Open J. 2017, 4, 40–48. [Google Scholar] [CrossRef]
  19. Boaitey, Y.A.; Nkrumah, B.; Idriss, A.; Tay, S.C.K. Gastrointestinal and urinary tract pathogenic infections among HIV seropositive patients at the Komfo Anokye Teaching Hospital in Ghana. BMC Res. Notes 2012, 5, 454. [Google Scholar] [CrossRef] [Green Version]
  20. Opoku, Y.K.; Boampong, J.; Ayi, I.; Kwakye-Nuako, G.; Obiri-Yeboah, D.; Koranteng, H.; Ghartey-Kwansah, G.; Asare, K.K. Socio-Behavioral Risk Factors Associated with Cryptosporidiosis in HIV/AIDS Patients Visiting the HIV Referral Clinic at Cape Coast Teaching Hospital, Ghana. Open AIDS J. 2018, 12, 106–116. [Google Scholar] [CrossRef] [Green Version]
  21. Ahmed, S.A.; Karanis, P. An overview of methods/techniques for the detection of Cryptosporidium in food samples. Parasitol. Res. 2018, 117, 629–653. [Google Scholar] [CrossRef] [PubMed]
  22. Shimelis, T.; Tadesse, E. Performance evaluation of point-of-care test for detection of Cryptosporidium stool antigen in children and HIV infected adults. Parasites Vectors 2014, 7, 227. [Google Scholar] [CrossRef] [Green Version]
  23. Samie, A.; Hlungwani, A.H.; Mbati, P.A. Prevalence and risk factors of Cryptosporidium species among domestic animals in rural communities in Northern South Africa. Trop. Biomed. 2017, 34, 636–647. [Google Scholar]
  24. Anim-Baidoo, I.; Narh, C.; Obiri, D.; Ewerenonu-Laryea, C.; Donkor, E.; Adjei, D.; Markakpo, U.; Asmah, R.; Brown, C.; Armah, G.; et al. Cryptosporidial Diarrhoea in Children at a Paediatric Hospital in Accra, Ghana. Int. J. Trop. Dis. Health 2015, 10, 1–13. [Google Scholar] [CrossRef]
  25. Ghoshal, U.; Jain, V.; Dey, A.; Ranjan, P. Evaluation of enzyme-linked immunosorbent assay for stool antigen detection for the diagnosis of cryptosporidiosis among HIV negative immunocompromised patients in a tertiary care hospital of northern India. J. Infect. Public Heal. 2018, 11, 115–119. [Google Scholar] [CrossRef] [PubMed]
  26. Taha, A.A.; Mohammed, F.A.; Mohamed, S.M.A. Cryptosporidium among asymptomatic food handlers. J. Egypt. Soc. Parasitol. 2017, 47, 333–340. [Google Scholar] [CrossRef]
  27. Joint United Nations Programme on HIV/AIDS. Global HIV & AIDS Statistics—2021 Fact Sheet. 2021. Available online: https://embargo.unaids.org/static/files/uploaded_files/UNAIDS_2021_FactSheet_en_em.pdf (accessed on 10 August 2021).
  28. UNAIDS. UNAIDS Data 2020. 2020, pp. 132–135. Available online: https://www.unaids.org/sites/default/files/media_asset/2020_aids-data-book_en.pdf (accessed on 16 September 2020).
  29. WHO. HIV Country Profile; World Health Organisation: Geneva, Switzerland, 2017; pp. 1–8. Available online: http://cfs.hivci.org/country-factsheet.html (accessed on 25 October 2019).
  30. Valderrama, A.L.; Hlavsa, M.C.; Cronquist, A.; Cosgrove, S.; Johnston, S.P.; Roberts, J.M.; Stock, M.L.; Xiao, L.; Xavier, K.; Beach, M.J. Multiple risk factors associated with a large statewide increase in cryptosporidiosis. Epidemiol. Infect. 2009, 137, 1781–1788. [Google Scholar] [CrossRef] [PubMed]
  31. Bouzid, M.; Kintz, E.; Hunter, P. Risk factors for Cryptosporidium infection in low and middle income countries: A systematic review and meta-analysis. PLoS Negl. Trop. Dis. 2018, 12, e0006553. [Google Scholar] [CrossRef] [PubMed]
  32. Ghana Statistical Service. 2010 Population & Housing Census. 2010. Available online: https://statsghana.gov.gh/gssmain/storage/img/marqueeupdater/Census2010_Summary_report_of_final_results.pdf (accessed on 16 October 2018).
  33. Legan, D.; Vandeven, M.H. Sampling Techniques, 3rd ed.; John Wiley & Sons: New York, NY, USA, 2003. [Google Scholar]
  34. Kwakye-Nuako, G.; Boampong, J.; Dong, M.K.; Obiri-Yeboah, D.; Opoku, Y.K.; Amoako-Sakyi, D.; Asare, K.K. Modulation of cyptosporidiosis by CD4 levels in chronic diarrhoea HIV/AIDS individuals visiting Tarkwa Municipal hospital, Ghana. Asian Pac. J. Trop. Dis. 2016, 6, 770–775. [Google Scholar] [CrossRef]
  35. Acquah, F.; Tay, S.C.K.; Frimpong, E.H. Prevalence of Cryptosporidium and Isospora Belli in HIV/AIDS Patients at KomfoAnokye Teaching Hospital, Kumasi-Ghana. Int. J. Pure Appl. Sci. Technol. 2012, 8, 26–33. [Google Scholar]
  36. Casmo, V.; Lebbad, M.; Maungate, S.; Lindh, J. Occurrence of Cryptosporidium spp. and Cystoisospora belli among adult patients with diarrhoea in Maputo, Mozambique. Heliyon 2018, 4, e00769. [Google Scholar] [CrossRef] [Green Version]
  37. Srisuphanunt, M.; Suvedyathavorn, V.; Suputtamongkol, Y.; Arnantapunpong, S.; Wiwanitkit, V.; Satitvipawee, P.; Tansupasawadikul, S. Potential risk factors for Cryptosporidium infection among HIV/AIDS patients in central areas of Thailand. J. Public Health 2007, 16, 173–182. [Google Scholar] [CrossRef]
  38. Ghafari, R.; Rafiei, A.; Tavalla, M.; Choghakabodi, P.M.; Nashibi, R.; Rafiei, R. Prevalence of Cryptosporidium species isolated from HIV /AIDS patients in southwest of Iran. Comp. Immunol. Microbiol. Infect. Dis. 2018, 56, 39–44. [Google Scholar] [CrossRef] [PubMed]
  39. Olopade, B.; Ogunniyi, T.; Oyekunle, A.; Odetoyin, B.; Adegoke, A. Cryptosporidiosis: Prevalence, risk factors and diagnosis in adult HIV-infected patients at Obafemi Awolowo University Teaching Hospitals Complex (OAUTHC), Ile-Ife, Osun State, Nigeria. Int. J. Med. Biomed. Res. 2017, 6, 18–29. [Google Scholar] [CrossRef]
  40. Sharma, P.; Sharma, A.; Sehgal, R.; Malla, N.; Khurana, S. Genetic diversity of Cryptosporidium isolates from patients in North India. Int. J. Infect. Dis. 2013, 17, e601–e605. [Google Scholar] [CrossRef] [Green Version]
  41. Wumba, R.D.; Zanga, J.; Mbanzulu, K.M.; Mandina, M.N.; Kahindo, A.K.; Aloni, M.N.; Ekila, M.B. Cryptosporidium identification in HIV-Infected Humans. Experience from Kinshasa, the Democratic Republic of Congo. Acta Parasitol. 2015, 60, 638–644. [Google Scholar] [CrossRef]
  42. Annison, L.; Dompreh, A.; Adu-Sarkodie, Y. The Immunological Response of HIV-Positive Patients Initiating Haart at the Komfo Anokye Teaching Hospital, Kumasi, Ghana. Ghana Med. J. 2013, 47, 164–170. [Google Scholar] [PubMed]
  43. Manaye, G.A.; Abateneh, D.D.; Kebede, K.M.; Belay, A.S. Immunological Response During HAART and Determinants of Current CD4+ T-Cell Count Among HIV/AIDS Patients Attending University of Gondar Referral Hospital, Northwest Ethiopia. HIV/AIDS Res. Palliat. Care 2020, ume 12, 295–306. [Google Scholar] [CrossRef]
  44. Erhabor, O.; Obunge, O.; Awah, I. Cryptosporidiosis among HIV-infected persons in the Niger Delta of Nigeria. Niger. J. Med. 2011, 20, 372–375. [Google Scholar] [PubMed]
  45. Cacciò, S.M.; Pozio, E. Advances in the epidemiology, diagnosis and treatment of cryptosporidiosis. Expert Rev. Anti-Infect. Ther. 2006, 4, 429–443. [Google Scholar] [CrossRef] [PubMed]
  46. Gait, R.; Soutar, R.H.; Hanson, M.; Fraser, C.; Chalmers, R. Outbreak of cryptosporidiosis among veterinary students. Veter. Rec. 2008, 162, 843–845. [Google Scholar] [CrossRef]
  47. De Lucio, A.; Bailo, B.; Aguilera, M.; Cardona, G.A.; Fernández-Crespo, J.C.; Carmena, D. No molecular epidemiological evidence supporting household transmission of zoonotic Giardia duodenalis and Cryptosporidium spp. from pet dogs and cats in the province of Álava, Northern Spain. Acta Trop. 2017, 170, 48–56. [Google Scholar] [CrossRef]
  48. Kudah, C.; Sovoe, S.; Baiden, F. Parasitic contamination of commonly consumed vegetables in two markets in Ghana. Ghana Med. J. 2018, 52, 88–93. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  49. Duedu, K.O.; Yarnie, E.A.; Tetteh-Quarcoo, P.B.; Attah, S.K.; Donkor, E.S.; Ayeh-Kumi, P.F. A comparative survey of the prevalence of human parasites found in fresh vegetables sold in supermarkets and open-aired markets in Accra, Ghana. BMC Res. Notes 2014, 7, 1–6. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  50. In the market for proper sanitation. Bull. World Health Organ. 2010, 88, 167–168. [CrossRef]
  51. Tumwebaze, I.K.; Mosler, H.-J. Shared toilet users’ collective cleaning and determinant factors in Kampala slums, Uganda. BMC Public Health 2014, 14, 1260. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  52. WHO; UNICEF. Progress on Household Drinking Water, Sanitation, and Hygiene 2000–2017 Special Focus on Inequalities. 2019. Available online: https//www.who.int/water_sanitation_health/publications/jmp-2019-full-report.pdf? (accessed on 24 April 2020).
Figure 1. Map of the Central region of Ghana, showing the location of study facilities.
Figure 1. Map of the Central region of Ghana, showing the location of study facilities.
Tropicalmed 06 00210 g001
Table 1. Socio-Demographic Characteristics of Study Participants.
Table 1. Socio-Demographic Characteristics of Study Participants.
CharacteristicMean (SD)/Range/n (%)
Age (years)
Mean45.8 (±11.7)
Range18–77
≤2934 (8.1)
30–44149 (35.7)
45–59172 (41.1)
>5963 (15.1)
Sex
Male77 (18.4)
Female341 (81.6)
Occupation
Not working46 (11.0)
Farming/Fishing119 (28.5)
Trading164 (39.2)
Others89 (21.3)
Educational level
No formal education106 (25.4)
Primary91 (21.8)
Middle/Junior High158 (37.7)
Senior High and above63 (15.1)
Size of Household
≤5 members254 (60.8)
>5 members164 (39.2)
Location
Rural122 (29.2)
Urban296 (70.8)
Duration on ART
0 month *23 (5.5)
1–12 months119 (28.5)
≥12 months276 (66.0)
* Participants were not yet on HAART.
Table 2. Prevalence of Cryptosporidium infection and Association with Sociodemographic Characteristics of Participants.
Table 2. Prevalence of Cryptosporidium infection and Association with Sociodemographic Characteristics of Participants.
VariablesNumber of
Respondents
Positives
(%)
95% CIp-Value
ELISA results41826 (6.2)3.90–8.54-
Sex
Male778 (10.4)3.42–17.360.114
Female34118 (5.3)2.89–7.66
Age in years
≤29341 (2.9)−3.04–8.930.255
30–4414914 (9.4)4.66–14.14
45–591728 (4.7)1.47–7.83
>59633 (4.8)−0.64–10.17
Occupation
Not working464 (8.7)0.24–17.160.795
Farming and fishing1197 (5.9)1.59–10.17
Trading16411 (6.7)2.84–10.58
Others894 (4.5)0.11–8.88
Educational level
No formal education1069 (8.5)3.10–13.880.577
Primary915 (5.5)0.72–10.27
Middle/Junior High15810 (6.3)2.49–10.17
Senior High/Tertiary632 (3.2)−1.28–7.63
Size of Household
≤5 members25417 (6.7)3.54–9.640.683
>5 members1649 (5.5)1.93–8.85
Location
Rural1227 (5.7)1.59–9.920.793
Urban29619 (6.4)3.61–9.23
Table 3. Association between Clinical Symptoms, Duration on ART and Cryptosporidium Infection.
Table 3. Association between Clinical Symptoms, Duration on ART and Cryptosporidium Infection.
VariablesNumber of
Respondents (%)
Positives
(%)
95% CIp-Value
Diarrhoea
YES102 (24.4)6 (5.9)1.24–10.530.871
NO316 (75.6)20 (6.3)3.63–9.03
Nausea
YES84 (20.1)6 (7.1)1.52–12.770.695
NO334 (79.9)20 (6.0)3.43–8.55
Vomiting
YES39 (9.3)2 (5.1)−2.12–12.370.761
NO379 (90.7)24 (6.3)3.87–8.80
Abdominal pains
YES120 (28.7)9 (7.5)2.72–12.280.492
NO298 (71.3)17 (5.7)3.06–8.35
Duration on ART
0 month23 (5.5)1 (4.3)−4.67–13.360.496
1–12 months119 (28.5)10 (8.4)3.35–13.46
>12 months276 (66.0)15 (5.4)2.74–8.13
Table 4. Association between Environmental Factors and Cryptosporidium Infection.
Table 4. Association between Environmental Factors and Cryptosporidium Infection.
VariablesNumber of
Respondents (%)
Positives
(%)
95% CIp-Value
Drinking water source
Tap227 (54.3)16 (7.1)3.69–10.40.936
Sachet135 (32.3)7 (5.2)1.40–8.97
Borehole15 (3.6)1 (6.7)−7.63–20.97
Well26 (6.2)1 (3.9)−4.08–11.77
Stream15 (3.6)1 (6.7)−7.63–20.97
Toilet facility used
Water closet (private)81 (19.4)7 (8.6)2.34–14.890.132
Water closet (public)18 (4.3)3 (16.7)−2.40–35.74
KVIP/Pit latrine252 (60.3)14 (5.6)2.71–8.40
Open defecation67 (16.0)2(2.99)−1.20–7.17
Livestock at home
YES287 (68.7)16 (5.6)2.90–8.250.419
NO131 (31.3)103.03–12.24
Pets at home
YES306 (73.2)203.75–9.320.659
NO112 (26.8)61.12–9.59
KVIP—Kumasi Ventilated Improved Pit latrine.
Table 5. Association between Behavioral Factors and Cryptosporidium Infections.
Table 5. Association between Behavioral Factors and Cryptosporidium Infections.
VariableNumber of Respondents (%)Positives
(%)
95% CIp-Value
Wash hands always
before meals
YES402 (96.2)22 (5.5)3.24–7.71* 0.013
NO16 (3.8)4 (25.0)1.17–48.83
Wash fruits always
before eating
YES246 (58.9)11 (4.5)1.87–7.070.077
NO172 (41.1)15 (8.5)4.46–12.98
Wash vegetables always before
eating them
YES401 (95.9)22 (5.5)3.25–7.72* 0.016
NO17 (4.1)4 (23.5)1.05–46.01
Wash hands with soap after
visiting the toilet
YES401 (95.9)25 (6.2)3.86–8.611.000
NO17 (4.0)1 (5.9)−6.59–18.4
Change diapers of
young children
YES109 (26.1)7 (6.4)1.75–11.100.919
NO309 (73.9)19 (6.2)3.46–8.84
* Statistically significant at p ≤ 0.05.
Table 6. Multivariate analysis of risk factors for Cryptosporidium Infection.
Table 6. Multivariate analysis of risk factors for Cryptosporidium Infection.
Variables Prevalence (%)Odds Ratio (95% CI)p-Value
Sex
Male10.42.08(0.83–5.23)0.118
Female5.31
Toilet facility used regularly
Water closet
(private)
8.63.23(0.58–15.59)0.171
Water closet (public)16.78.83(1.22–64.13)0.031 *
KVIP/Pit latrine5.62.20(0.46–10.45)0.320
Open defecation3.01
Always wash hands before meals
No25.02.43(0.54–10.97)0.248
Yes5.51
Always wash vegetables before eating
No23.53.21(0.71–14.64)0.132
Yes5.51
Always wash fruits before eating
No8.71.77 (0.75–4.19)0.195
Yes4.51
* Statistically significant at p ≤ 0.05, KVIP—Kumasi ventilated improved pit latrine.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Dankwa, K.; Nuvor, S.V.; Obiri-Yeboah, D.; Feglo, P.K.; Mutocheluh, M. Occurrence of Cryptosporidium Infection and Associated Risk Factors among HIV-Infected Patients Attending ART Clinics in the Central Region of Ghana. Trop. Med. Infect. Dis. 2021, 6, 210. https://doi.org/10.3390/tropicalmed6040210

AMA Style

Dankwa K, Nuvor SV, Obiri-Yeboah D, Feglo PK, Mutocheluh M. Occurrence of Cryptosporidium Infection and Associated Risk Factors among HIV-Infected Patients Attending ART Clinics in the Central Region of Ghana. Tropical Medicine and Infectious Disease. 2021; 6(4):210. https://doi.org/10.3390/tropicalmed6040210

Chicago/Turabian Style

Dankwa, Kwabena, Samuel Victor Nuvor, Dorcas Obiri-Yeboah, Patrick Kwame Feglo, and Mohamed Mutocheluh. 2021. "Occurrence of Cryptosporidium Infection and Associated Risk Factors among HIV-Infected Patients Attending ART Clinics in the Central Region of Ghana" Tropical Medicine and Infectious Disease 6, no. 4: 210. https://doi.org/10.3390/tropicalmed6040210

APA Style

Dankwa, K., Nuvor, S. V., Obiri-Yeboah, D., Feglo, P. K., & Mutocheluh, M. (2021). Occurrence of Cryptosporidium Infection and Associated Risk Factors among HIV-Infected Patients Attending ART Clinics in the Central Region of Ghana. Tropical Medicine and Infectious Disease, 6(4), 210. https://doi.org/10.3390/tropicalmed6040210

Article Metrics

Back to TopTop